- Report
- July 2021
- 112 Pages
Global
From €4050EUR$4,450USD£3,472GBP
- Report
- September 2023
- 331 Pages
Global
From €4050EUR$4,450USD£3,472GBP
- Report
- August 2023
- 145 Pages
Global
From €2867EUR$3,150USD£2,458GBP
- Report
- March 2024
- 101 Pages
From €3140EUR$3,450USD£2,692GBP
- Report
- March 2024
- 138 Pages
Asia Pacific
From €3140EUR$3,450USD£2,692GBP
- Report
- March 2024
- 162 Pages
Europe
From €3140EUR$3,450USD£2,692GBP
- Report
- April 2022
- 295 Pages
Global
From €4050EUR$4,450USD£3,472GBP
- Report
- September 2023
- 160 Pages
Global
From €3275EUR$3,599USD£2,808GBP
- Report
- May 2023
- 140 Pages
Global
From €4504EUR$4,949USD£3,861GBP
- Report
- November 2021
Global
From €6826EUR$7,500USD£5,852GBP
- Report
- December 2021
Global
From €6826EUR$7,500USD£5,852GBP
- Report
- October 2022
- 171 Pages
Global
From €3249EUR$3,570USD£2,785GBP
- Report
- September 2022
- 296 Pages
Global
From €3249EUR$3,570USD£2,785GBP
- Book
- August 2022
- 560 Pages
- Book
- September 2020
- 608 Pages
- Book
- September 2020
- 528 Pages
- Book
- September 2020
- 1136 Pages
- Book
- February 2019
- 480 Pages
- Book
- February 2009
- 1028 Pages

The Viral Infection market within the context of Infectious Disease Testing is a rapidly growing sector of the healthcare industry. It is focused on the development of tests that can detect the presence of viruses in a patient's body. These tests are used to diagnose and monitor the progression of viral infections, such as influenza, HIV, and hepatitis. They can also be used to detect the presence of other infectious agents, such as bacteria and fungi.
The Viral Infection market is driven by the increasing prevalence of viral infections, as well as the need for more accurate and timely diagnosis. The development of new technologies, such as next-generation sequencing and PCR-based assays, has enabled the development of more sensitive and specific tests. This has led to the emergence of a number of companies offering a range of tests for the detection of viral infections.
Some of the major companies in the Viral Infection market include Abbott Laboratories, Becton Dickinson, Cepheid, Hologic, and Roche Diagnostics. These companies offer a range of tests for the detection of viral infections, including PCR-based assays, ELISA-based assays, and next-generation sequencing-based assays. Show Less Read more